Lineage, Inc. Common Stock (LINE)vsChiron Real Estate Inc. (XRN)
LINE
Lineage, Inc. Common Stock
$37.04
+0.43%
REAL ESTATE · Cap: $9.19B
XRN
Chiron Real Estate Inc.
$34.96
-1.44%
REAL ESTATE · Cap: $984.64M
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 3517% more annual revenue ($5.36B vs $148.06M). LINE leads profitability with a -1.9% profit margin vs -3.9%. XRN earns a higher WallStSmart Score of 41/100 (D).
LINE
Avoid34
out of 100
Grade: F
XRN
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+75.9%
Fair Value
$161.49
Current Price
$37.04
$124.45 discount
Intrinsic value data unavailable for XRN.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Reasonable price relative to book value
Strong operational efficiency at 25.1%
Areas to Watch
0.0% earnings growth
ROE of -1.2% — below average capital efficiency
Revenue declined 0.2%
Distress zone — elevated risk
0.0% earnings growth
Smaller company, higher risk/reward
Expensive relative to growth rate
ROE of -1.3% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : XRN
The strongest argument for XRN centers on Price/Book, Operating Margin.
Bear Case : LINE
The primary concerns for LINE are EPS Growth, Return on Equity, Revenue Growth.
Bear Case : XRN
The primary concerns for XRN are EPS Growth, Market Cap, PEG Ratio.
Key Dynamics to Monitor
XRN is growing revenue faster at 9.2% — sustainability is the question.
LINE generates stronger free cash flow (78M), providing more financial flexibility.
Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
XRN scores higher overall (41/100 vs 34/100). LINE offers better value entry with a 75.9% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm focused on regenerative medicine, specifically developing cutting-edge cell therapy solutions for treating debilitating conditions, including ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust network of strategic collaborations, Lineage is poised to transform patient care through innovative therapeutic interventions. The company's commitment to advancing its diverse product pipeline and expediting clinical research positions it as an attractive investment opportunity for institutional investors seeking to engage in the forefront of healthcare advancements.
Visit Website →Chiron Real Estate Inc.
REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA
Chiron Real Estate Inc. is a net-lease medical REIT that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?